Experts have hailed the ‘landmark’ decision from the National Institute for Health and Care Excellence to approve the treatment for NHS use

Experts have hailed the ‘landmark’ decision from the National Institute for Health and Care Excellence to approve the treatment for NHS use

Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years

Doctors today hailed a 'milestone' moment in ovarian cancer treatment after a drug that gives patients precious extra months was made available on the NHS today.

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…